InhaleRx Limited (ASX:IRX) Executes Study Order for Phase 2 IRX-211 Trial
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
InhaleRx Limited (ASX:IRX) executes Study Order for Phase 2 IRX-211 trial targeting breakthrough cancer pain.
Silver Mines Limited (ASX:SVL) commences diamond drilling at the Elsienora Project, targeting significant gold and silver mineralisation.
Thor Energy PLC (ASX:THR) converts its licence to an RSEL, advancing hydrogen and helium exploration projects.
Strategic Energy Resources Ltd (ASX:SER) updates on its Ambergate Heavy Mineral Sands Project with new retention licences and resource estimates.
NIMY Resources (ASX:NIM) reports significant gallium and Cu-Ni-PGE discoveries and a strategic partnership with M2i Global to supply critical minerals to US defense.
Strickland Metals Limited (ASX:STK) reports up to 88.6% gold recovery at Horse Well Gold Camp, strengthening the Yandal Project’s growth prospects.
Top End Energy (ASX:TEE) selects first well site for its Serpentine Natural Hydrogen Project, advancing operations in Kansas, USA.
Proteomics International (ASX:PIQ) launches PromarkerD, a predictive test for diabetic kidney disease, enhancing early diagnosis and intervention.
GreenTech Metals (ASX:GRE) completes successful drilling at Whundo Copper Project, confirming significant sulphide intersections and promising resource expansion.
Sarytogan Graphite (ASX:SGA) advances water drilling efforts in Kazakhstan to secure essential water supply for its graphite project.